Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA

相似書籍

• Advantages of a genomic DNA-based next-generation sequencing assay for detection of mutant NPM1 measurable residual disease in AML
  由: Christian M. Vonk, et al.
  出版: (2025-03-01)
• Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia
  由: Emma L. Boertjes, et al.
  出版: (2025-10-01)
• P404: PROGNOSTIC IMPACT OF CEBPA-MUTATIONAL SUBGROUPS IN ADULT AML – RESULTS OF A LARGE METAANALYSIS IN MORE THAN 1000 CEBPA-MUTANT PATIENTS
  由: J.-A. Georgi, et al.
  出版: (2022-06-01)
• Impact of baseline genetic profile and treatment on outcome and hematological toxicity in CEBPA-mutated AML
  由: Francesco Mannelli, et al.
  出版: (2025-03-01)
• S119: CEBPA AND TET2 MUTATIONS COOPERATE TO INDUCE AGGRESSIVE AML VIA GATA-2 DOWNREGULATION
  由: E. Heyes, et al.
  出版: (2022-06-01)